News
For years, Pfizer was the only drugmaker with treatments for the disease, called ATTR-CM, but BridgeBio’s CEO said in an ...
Albert Bourla said Pfizer is being "frugal" with investments because of the uncertainty surrounding tariffs.
Pfizer’s first-quarter revenue missed analyst estimates as it faces an “uncertain and volatile external environment.” ...
3don MSN
Unlike other companies grappling with evolving trade policy, Pfizer didn't revise its full-year outlook Tuesday.
The company disclosed revenue of $13.7 billion and adjusted earnings of $0.92 per share, compared to consensus estimates of ...
Big pharmaceutical companies as well as smaller biotechs have been hoping to score a win in one of today's highest-growth ...
Pfizer and Arvinas have axed two phase 3 trials from their estrogen receptor (ER) degrader R&D plan in the wake of mixed data ...
Madison Realty Capital set a company high watermark with its $700 million financing package, which is being finalized.
After years of falling Covid treatment sales, lukewarm drug launches and a fizzled out weight-loss play, Pfizer is focusing on cost-cutting and reinvesting in new drug research in hopes that it can ...
Three Native American healthcare facilities to benefit from pharmaceutical giant’s contribution aimed at boosting services ...
DC News Now on MSN8h
West Virginia counties, cities to receive Pfizer settlement checksFriday morning, West Virginia Attorney General JB McCuskey announced his office is distributing checks to cities and counties ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback